(S)-Methyl 3-bromo-2-((tert-butoxycarbonyl)amino)propanoate, 95%, 250mg

(R)-3-tert-Butoxycarbonylamino-4-phenyl-butyric acid, 95.0%, 1g

(3aR,8aS)-2-(Pyridin-2-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole, 97%, 1g

Cyclohexaneacetic acid, 4-[[(1,1-dimethylethoxy)carbonyl]amino]-, ethyl ester, trans-, 95%, 5g

TERT-BUTYL (E)-(3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)ALLYL)CARBAMATE, 95.0%, 500mg

1-Butyl-3-methyl-1H-imidazol-3-ium nitrate, 95.0%, 5g

Ethyl 2,2,2-trichloroacetate, 95.0%, 25g

Ethyl 3-oxo-3-(3-pyridyl)propionate, 95.0%, 5g

Glass vials with rolled rim Tall, 25 ml, Height, 50 mm, 200 Piece(s)

n-{[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]methyl}cyclopropanamine, 98%, 1g

3-Methyl-1H-pyrazole-5-carboxamide, 95.0%, 1g

[3-(4-Methoxyphenyl)isoxazol-5-yl]methanol, 95.0%, 25g

2-(Diethylamino)ethyl Bromide Hydrobromide>98.0%(T)500g